A potential new immune-based therapy to treat precancers in the cervix completely eliminated both the lesion and the underlying HPV infection in a third of women enrolled in a clinical trial.
Apr 4, 2019
0
55
(HealthDay)—Human papillomavirus (HPV)-negative women have low long-term incidence of cervical cancer and cervical intraepithelial neoplasia (CIN) grade 3 or worse (CIN3+), which supports an extension of the cervical screening ...
Oct 7, 2016
0
2
(HealthDay)—HIV-seropositive women with cervical intraepithelial neoplasia (CIN) grade ≥3 (CIN3+) are less likely to have human papillomavirus (HPV) 16, according to a study published in the March issue of the American ...
Mar 16, 2016
0
7
Human papillomavirus (HPV) testing of self-collected specimens may be a more effective way to screen for cervical cancer in low-resource settings compared to visual inspection with acetic acid (VIA) and liquid-based cytology ...
Jan 23, 2012
0
0
(HealthDay)—The use of primary human papillomavirus (HPV) testing versus cytology results in reduced likelihood of cervical intraepithelial neoplasia (CIN) grade 3 or worse (CIN3+) at 48 months, according to a study published ...
Jul 4, 2018
0
3
New evidence published in the Cochrane Library today provides further information on the benefits and harms of different human papillomavirus (HPV) vaccines and vaccine schedules in young women and men.
Nov 22, 2019
0
2
A study of 1.3 million women in England has provided evidence to support the extension of cervical cancer screening intervals from three years to five years for those that have a negative screen result.
May 31, 2022
0
64
Actively monitoring abnormal cells (lesions) that line the cervix rather than removing them straight away is associated with an increased long-term risk of cervical cancer, suggests a study published by The BMJ today.
Nov 29, 2023
0
14
A new swab test that identifies potentially dangerous cervical cell changes up to four years before they happen has been developed by researchers from UCL and the University of Innsbruck.
Oct 20, 2022
0
55
Vanderbilt University Medical Center is participating in an international study to determine the effectiveness of a new therapeutic vaccine for treating women with precancerous changes on the cervix.
Dec 10, 2018
0
4
